These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2488007)
1. Enhanced streptokinase-induced thrombolysis using heparin in a rabbit model. Kolts RL; Maki HS; Kuehner ME; Roberts RC; Sautter RD J Invest Surg; 1989; 2(4):431-6. PubMed ID: 2488007 [TBL] [Abstract][Full Text] [Related]
2. A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase. Wikström K; Mattsson C; Pohl G Thromb Res; 1993 May; 70(3):217-24. PubMed ID: 8392227 [TBL] [Abstract][Full Text] [Related]
3. Heparin compromises streptokinase-induced arterial patency in rabbits. Vlasin M; Rak J; Weitz JI; Peng L; Gumulec J; Johnston M; Klement P Thromb Res; 2005; 115(5):427-34. PubMed ID: 15733977 [TBL] [Abstract][Full Text] [Related]
4. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit. Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050 [TBL] [Abstract][Full Text] [Related]
12. Successful clot lysis using low dose of streptokinase in 22 neonates with aortic thromboses. Cheah FC; Boo NY; Rohana J; Yong SC J Paediatr Child Health; 2001 Oct; 37(5):479-82. PubMed ID: 11885713 [TBL] [Abstract][Full Text] [Related]
13. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators. Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216 [TBL] [Abstract][Full Text] [Related]
14. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model. Perkins WR; Vaughan DE; Plavin SR; Daley WL; Rauch J; Lee L; Janoff AS Thromb Haemost; 1997 Jun; 77(6):1174-8. PubMed ID: 9241753 [TBL] [Abstract][Full Text] [Related]
15. Streptokinase clot lysis in acute occlusions of the cranial circulation: study in rabbits. Centeno RS; Hackney DB; Rothrock JR AJNR Am J Neuroradiol; 1985; 6(4):589-94. PubMed ID: 3927676 [TBL] [Abstract][Full Text] [Related]
16. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Leach JK; O'Rear EA; Patterson E; Miao Y; Johnson AE Thromb Haemost; 2003 Jul; 90(1):64-70. PubMed ID: 12876627 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. Lengyel M; Vegh G; Vandor L J Heart Valve Dis; 1999 Mar; 8(2):167-73. PubMed ID: 10224577 [TBL] [Abstract][Full Text] [Related]
18. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728. Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524 [TBL] [Abstract][Full Text] [Related]
19. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase. Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274 [TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]